Pharm-Olam
Pharm-Olam is a contract research organization that provides clinical trial management and related services to pharmaceutical, biotechnology, and medical device companies. The company supports Phase I–IV clinical studies across multiple therapeutic areas, offering services such as project management, monitoring, data management, and regulatory support. It generates revenue through fee-for-service and outsourced clinical development contracts with life sciences sponsors.
- IT Consulting & Implementation
- Revenue
- $150.0M
- Employees
- 700
- Founded
- 1994
- Headquarters
- Houston, United States of America
What 5 Arbolus experts think of Pharm-Olam
NPS scores from expert insights range from 5 to 7, reflecting moderate satisfaction levels. Renewal intent is predominantly 'Not Sure' (80% of experts), with only one clear 'No' and zero confirmed renewals. Implementation stickiness shows a split: 60% have been using the solution for more than one year, 20% less than a year, and 20% are at the pilot stage. Key inferred themes are moderate satisfaction, high uncertainty about renewal, and a user base engaged in mature implementations but not committed to ongoing contracts.Overall Customer Sentiment: Neutral
Who reviewed Pharm-Olam
- C-Suite 20% (1)
- Director 80% (4)
Employer names and spend open once the report publishes.
Tell us when the Pharm-Olam report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
-40 Net Promoter Score, from 5 scored reviews- Promoters 1
- Passives 1
- Detractors 3
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 0%Plan to renew, by seniority
- 0% 1 answer
- 0% 3 answers
- 5.7/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
For people who use Pharm-Olam
Do you use Pharm-Olam at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 5 customers of Pharm-Olam have already contributed
Takes a few minutes. Your identity stays anonymous.